The Jill Roberts Institute for Research in Inflammatory Bowel Disease is now home to Weill Cornell Medicine’s new Microbiome Core, https://www.microbiome.weill.cornell.edu/,which officially opens June 1. The core’s mission is to provide researchers with the technological platforms required to perform microbiome sequencing and analysis.
A microbiome is the aggregate of microorganisms living in an environment and the human microbiome consists of microorganisms that live in the human body.
“There’s a major biomedical revolution right now in understanding how the microbiome contributes to disease, and we are excited to be a part of that,” said Dr. Randy Longman, an assistant professor of medicine and a gastroenterologist at the Jill Roberts Center for Inflammatory Bowel Disease. “Now scientists are researching how the microbiome plays a role in normal development, the function of the immune system, metabolism, and the susceptibility to diseases including allergies, arthritis, cancer, inflammatory bowel disease and more.” To continue reading...